Latest Japan News

Page 1 of 53
Innovaero Technologies has reported a $5.917 million FY2026 loss as it prepares to scale OWL drone production after its ASX debut and $40 million capital raise. The annual report shows a better-funded business, but one still reliant on government contracts, certification and forecast production work.
Victor Sage
Victor Sage
28 Oct 2026
Talga has signed a binding term sheet with Japan’s Dainen Materials to reserve up to 2,000 tonnes a year of Talnode-C anode material for five years from late 2027. The agreement advances Talga’s commercialisation, but final purchase volumes and a definitive supply contract remain outstanding.
Victor Sage
Victor Sage
28 Oct 2026
Saunders International says it expects revenue growth and sustained second-half margin improvement in FY27 after reporting record FY26 revenue of A$305.6 million. Its opportunity pipeline reached A$5.1 billion, although converting that pipeline into profitable work remains the central test.
Victor Sage
Victor Sage
27 Oct 2026
icetana AI returned to revenue growth in FY26, with sales up 31% to $2.47 million and annual recurring revenue reaching $2.6 million. The company remains loss-making, but entered FY27 with stronger recurring revenue, new distribution channels and $4.79 million in cash.
Sophie Babbage
Sophie Babbage
27 Oct 2026
Foresta has secured acceptance of a Japanese patent for its rosin and terpene extraction technology while moving the Kawerau pine chemicals project through front-end design. But with $2.47 million in cash and estimated funding for 2.65 quarters, the next development stage will bring a financing question into sharper focus.
Victor Sage
Victor Sage
26 Oct 2026
Invex Therapeutics has agreed to acquire New Zealand biotech Rekover Therapeutics for shares and performance rights, adding a planned Phase 2a multiple sclerosis trial to its neurology portfolio. The transaction is paired with a $10 million placement, but would substantially expand the company’s share count and requires shareholder approval.
Ada Torres
Ada Torres
26 Oct 2026
Eagle Mountain Mining has emerged from FY2026 with no borrowings, a A$7.27 million accounting profit and a funded 20% interest in its Oracle Ridge copper project. The next test is whether Nittetsu’s drilling and earn-in spending can add value to an asset whose mineral resource has not changed since 2023.
Maxwell Dee
Maxwell Dee
22 Oct 2026
Energy Technologies has outlined two signed commercial arrangements for its Cogenic laser display technology, including a SYNCH purchasing framework worth up to US$10 million and a 5% royalty licence with Amalgamated Vision. The opportunity is meaningful, but the SYNCH arrangement carries no minimum order commitment and still depends on product specifications, acceptance and purchase orders.
Sophie Babbage
Sophie Babbage
22 Oct 2026
Telix reported US$245 million in unaudited third-quarter revenue, with Precision Medicine sales up 30% and full-year revenue and other income still expected to exceed US$1 billion. The quarter also advanced the proposed US$1.65 billion ITM merger, added FDA-approved Pixclara to the commercial portfolio and narrowed the R&D spending range.
Ada Torres
Ada Torres
21 Oct 2026
icetana AI has started FY27 with a sharp lift in recurring revenue and quarterly sales, while its Antara Core platform reached its first commercial deployment. The progress came alongside higher operating cash outflows and a $3.9 million cash balance.
Sophie Babbage
Sophie Babbage
20 Oct 2026
Boresight Ltd (ASX: BST) used its first quarter after listing to build inventory, expand its US manufacturing footprint and prepare for a larger military order, despite unaudited revenue of about A$829,000. Cash stood at A$5.39 million with no debt after operating outflows of A$2.28 million.
Victor Sage
Victor Sage
19 Oct 2026
Hazer Group has expanded its commercial pipeline through a paid Japanese utility study assessing hydrogen facilities of up to 300,000 tonnes per year, while its KBR alliance advances a standardised commercial-scale design. The company ended September with A$8.3 million in cash and reported A$12.9 million in pro-forma funding, but remains pre-revenue in the quarter.
Victor Sage
Victor Sage
19 Oct 2026

Browse the archive

Full archive